• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

止血过程中的细胞相互作用。

Cellular interactions in hemostasis.

作者信息

Hoffman M, Monroe D M, Roberts H R

机构信息

Duke University and Durham VA Medical Centers, The University of North Carolina, Chapel Hill, USA.

出版信息

Haemostasis. 1996;26 Suppl 1:12-6. doi: 10.1159/000217233.

DOI:10.1159/000217233
PMID:8904166
Abstract

Coagulation reactions normally occur on cell membranes in vivo. Using a cell-based in vitro model system, we have shown that where a factor is located, not simply how much is activated, is critically important in determining its role in hemostasis. Factor Xa activated on a tissue factor (TF)-bearing cell is not equivalent to factor Xa activated on a platelet surface. Factor IX and factor VIII are required for hemostasis because they combine to generate factor Xa on the platelet surface. Factor X activation by factor VIIa/TF does not compensate for a lack of factor IX or VIII because the factor Xa activated by VIIa/TF is located on the wrong surface for efficient thrombin generation.

摘要

凝血反应通常在体内的细胞膜上发生。使用基于细胞的体外模型系统,我们已经表明,凝血因子的定位,而不仅仅是其激活的量,对于确定其在止血中的作用至关重要。在表达组织因子(TF)的细胞上激活的因子Xa与在血小板表面激活的因子Xa并不等同。止血需要因子IX和因子VIII,因为它们结合可在血小板表面生成因子Xa。因子VIIa/TF激活因子X并不能弥补因子IX或VIII的缺乏,因为VIIa/TF激活的因子Xa位于错误的表面,无法有效生成凝血酶。

相似文献

1
Cellular interactions in hemostasis.止血过程中的细胞相互作用。
Haemostasis. 1996;26 Suppl 1:12-6. doi: 10.1159/000217233.
2
Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation.凝血因子IXa和Xa在组织因子依赖性凝血起始过程中发挥不同作用。
Blood. 1995 Sep 1;86(5):1794-801.
3
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.高剂量凝血因子VIIa(FVIIa)在基于细胞的止血模型中的作用。
Dis Mon. 2003 Jan;49(1):14-21. doi: 10.1053/mda.2003.29504b.
4
Cells and the activation of factor VII.细胞与凝血因子VII的激活
Haemostasis. 1996;26 Suppl 1:1-5. doi: 10.1159/000217229.
5
[The role of tissue factor and its inhibitor in hemostasis].[组织因子及其抑制剂在止血中的作用]
Przegl Lek. 1998;55(2):68-73.
6
Hemophilia as a defect of the tissue factor pathway of blood coagulation: effect of factors VIII and IX on factor X activation in a continuous-flow reactor.血友病作为凝血组织因子途径的缺陷:因子VIII和IX对连续流动反应器中因子X激活的影响。
Proc Natl Acad Sci U S A. 1990 Oct;87(19):7623-7. doi: 10.1073/pnas.87.19.7623.
7
Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor.蛋白酶信号传导与组织因子启动凝血的机制性耦合。
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7742-7. doi: 10.1073/pnas.141126698.
8
The lipoprotein-associated coagulation inhibitor.脂蛋白相关凝血抑制剂。
Prog Hemost Thromb. 1991;10:243-68.
9
The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX.因子VIII在活化因子IX激活人凝血因子X中的作用。
Thromb Haemost. 1985 Oct 30;54(3):654-60.
10
Potential role of recombinant factor VIIa as a hemostatic agent.重组凝血因子VIIa作为止血剂的潜在作用。
Clin Adv Hematol Oncol. 2003 Feb;1(2):112-9.

引用本文的文献

1
The Art and Science of Building a Computational Model to Understand Hemostasis.构建用于理解止血的计算模型的艺术与科学。
Semin Thromb Hemost. 2021 Mar;47(2):129-138. doi: 10.1055/s-0041-1722861. Epub 2021 Feb 26.
2
The Role of Gap Junction-Mediated Endothelial Cell-Cell Interaction in the Crosstalk between Inflammation and Blood Coagulation.缝隙连接介导的内皮细胞-细胞相互作用在炎症与凝血的串扰中的作用。
Int J Mol Sci. 2017 Oct 27;18(11):2254. doi: 10.3390/ijms18112254.
3
Evaluation of the antithrombotic abilities of non-vitamin K antagonist oral anticoagulants using the Total Thrombus-formation Analysis System.
使用全血栓形成分析系统评估非维生素K拮抗剂口服抗凝剂的抗血栓形成能力。
Heart Vessels. 2017 Mar;32(3):309-316. doi: 10.1007/s00380-016-0864-4. Epub 2016 Jun 21.
4
Traumatic Endotheliopathy: A Prospective Observational Study of 424 Severely Injured Patients.创伤性内皮病变:对424例重伤患者的前瞻性观察研究
Ann Surg. 2017 Mar;265(3):597-603. doi: 10.1097/SLA.0000000000001751.
5
Profiles of direct oral anticoagulants and clinical usage-dosage and dose regimen differences.直接口服抗凝剂的特点及临床应用-用法和剂量方案的差异。
J Intensive Care. 2016 Mar 10;4:19. doi: 10.1186/s40560-016-0144-5. eCollection 2016.
6
Viscoelasticity and Ultrastructure in Coagulation and Inflammation: Two Diverse Techniques, One Conclusion.凝血与炎症中的粘弹性和超微结构:两种不同技术,一个结论。
Inflammation. 2015 Aug;38(4):1707-26. doi: 10.1007/s10753-015-0148-7.
7
Influence of cellular and plasma procoagulant activity on the fibrin network.细胞和血浆促凝活性对纤维蛋白网络的影响。
Thromb Res. 2010 Apr;125 Suppl 1:S35-7. doi: 10.1016/j.thromres.2010.01.033. Epub 2010 Feb 16.
8
Remodeling the blood coagulation cascade.重塑凝血级联反应。
J Thromb Thrombolysis. 2003 Aug-Oct;16(1-2):17-20. doi: 10.1023/B:THRO.0000014588.95061.28.
9
Links between the immune and coagulation systems: how do "antiphospholipid antibodies" cause thrombosis?
Immunol Res. 2000;22(2-3):191-7. doi: 10.1385/IR:22:2-3:191.